Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bossard Holding Ord Shs BHAGF

Bossard Holding AG is a Switzerland-based holding company of the Bossard Group specialized in the procurement and sale of fastening elements. Through its operating entities, the Company focuses on the procurements of fasteners, including sales, technical and engineering support and inventory management. The Company’s business model covers three strategic areas: Product Solutions, providing product line, which covers standard parts, components developed in-house, branded products, as well as special parts; Application Engineering, which includes technical advice, and Customer Logistics, which offers logistic solutions. The Company has approximately 50 locations worldwide. The Company’s products include Bossard ecosyn, screws and fastening elements, standard fasteners, custom-made screws, nut and bolts for special uses and brand-name fasteners. The Company operates through its subsidiaries in Europe, America and Aisia.


PINL:BHAGF - Post by User

Post by whytestockson Feb 14, 2024 10:15pm
99 Views
Post# 35881075

Breaking: The US FDA Just Granted Priority Review of an MDMA

Breaking: The US FDA Just Granted Priority Review of an MDMA
NEWS: $SEEL Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSDAt the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change with the US FDA’s acceptance of a New Drug Application from Lykos Therapeutics for MDMA (...SEEL - Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

<< Previous
Bullboard Posts
Next >>